Accuvest Global Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.71M | Buy |
6,775
+4,377
| +183% | +$942K | 1.47% | 22 |
|
|
2026
Q1 | $522K | Sell |
2,398
-2,000
| -45% | -$444K | 0.49% | 35 |
|
|
2025
Q4 | $1M | Buy |
4,398
+247
| +6% | +$56.3K | 0.74% | 35 |
|
|
2025
Q3 | $961K | Buy |
4,151
+52
| +1% | +$10.6K | 0.6% | 33 |
|
|
2025
Q2 | $761K | Sell |
4,099
-1,690
| -29% | -$314K | 0.5% | 34 |
|
|
2025
Q1 | $1.21M | Buy |
+5,789
| New | +$1.13M | 1.03% | 24 |
|
|
2024
Q4 | – | Sell |
-4,987
| Closed | -$1.17M | – | 20 |
|
|
2024
Q3 | $1.17M | Buy |
+4,987
| New | +$931K | 1% | 24 |
|
|
2024
Q2 | – | Sell |
-6,653
| Closed | -$1.21M | – | 20 |
|
|
2024
Q1 | $1.21M | Buy |
6,653
+941
| +16% | +$162K | 0.53% | 40 |
|
|
2023
Q4 | $885K | Sell |
5,712
-651
| -10% | -$94.9K | 0.94% | 25 |
|
|
2023
Q3 | $948K | Buy |
6,363
+53
| +0.8% | +$7.78K | 0.52% | 45 |
|
|
2023
Q2 | $850K | Buy |
6,310
+3,412
| +118% | +$500K | 0.44% | 51 |
|
|
2023
Q1 | $462K | Sell |
2,898
-1,538
| -35% | -$235K | 0.21% | 76 |
|
|
2022
Q4 | $717K | Buy |
4,436
+2,218
| +100% | +$340K | 0.24% | 73 |
|
|
2022
Q3 | $298K | Hold |
2,218
| – | – | 0.2% | 75 |
|
|
2022
Q2 | $340K | Hold |
2,218
| – | – | 0.22% | 75 |
|
|
2022
Q1 | $360K | Sell |
2,218
-2,204
| -50% | -$320K | 0.18% | 79 |
|
|
2021
Q4 | $599K | Sell |
4,422
-1,597
| -27% | -$189K | 0.26% | 62 |
|
|
2021
Q3 | $649K | Buy |
6,019
+701
| +13% | +$80.1K | 0.31% | 57 |
|
|
2021
Q2 | $599K | Buy |
5,318
+557
| +12% | +$62.7K | 0.3% | 56 |
|
|
2021
Q1 | $515K | Buy |
+4,761
| New | +$509K | 0.28% | 59 |
|
|
2020
Q1 | – | Sell |
-150
| Closed | -$13K | – | 47 |
|
|
2019
Q4 | $13K | Sell |
150
-20
| -12% | -$1.66K | 0.03% | 40 |
|
|
2019
Q3 | $13K | Buy |
+170
| New | +$11.7K | 0.03% | 31 |
|
|
2019
Q1 | – | Sell |
-7,939
| Closed | -$732K | – | 107 |
|
|
2018
Q4 | $732K | Sell |
7,939
-1,967
| -20% | -$173K | 0.38% | 45 |
|
|
2018
Q3 | $937K | Buy |
9,906
+6,001
| +154% | +$569K | 0.35% | 51 |
|
|
2018
Q2 | $362K | Buy |
3,905
+3,846
| +6,519% | +$376K | 0.14% | 112 |
|
|
2018
Q1 | $6K | Hold |
59
| – | – | ﹤0.01% | 65 |
|
|
2017
Q4 | $6K | Sell |
59
-1
| -2% | -$94 | ﹤0.01% | 62 |
|
|
2017
Q3 | $5K | Sell |
60
-7,960
| -99% | -$606K | ﹤0.01% | 63 |
|
|
2017
Q2 | $582K | Buy |
8,020
+764
| +11% | +$51.4K | 0.19% | 50 |
|
|
2017
Q1 | $473K | Buy |
+7,256
| New | +$456K | 0.15% | 60 |
|
Other funds holding ABBV
Accuvest Global Advisors's ABBV Position: Q2 2026 in Review
Accuvest Global Advisors increased its AbbVie (ABBV) stake by 183% in Q2 2026, buying an estimated $942K and bringing the position to 6,775 shares worth $1.71M. The position accounts for 1.47% of the portfolio, ranked #22.
Accuvest Global Advisors first reported a position in ABBV in Q1 2017 and has held it in 30 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Accuvest Global Advisors held 6,775 shares of AbbVie worth $1.71M as of Q2 2026.
- Accuvest Global Advisors bought 4,377 AbbVie shares in Q2 2026, an estimated $942K.
- AbbVie made up 1.47% of Accuvest Global Advisors's portfolio in Q2 2026, its #22 holding.
- Accuvest Global Advisors first reported a position in AbbVie in Q1 2017 and has held it in 30 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Accuvest Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.